Evidence map›Paper›PMID 37922231›Full record

ArticlePLOS global public health2023

Hearing aid trial periods: Audiologists' thoughts and practices in South Africa.

Angie Heliopoulos, Nomfundo Moroe

Abstract read
In one paragraph

Article in PLOS global public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Angie HeliopoulosDepartment of Speech Pathology and Audiology, University of the Witwatersrand, Johannesburg, South Africa.ORCID https://orcid.org/0000-0001-7363-1477
Nomfundo MoroeDepartment of Speech Pathology and Audiology, University of the Witwatersrand, Johannesburg, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The process of adjusting and becoming accustomed to hearing aids may be best facilitated by providing a hearing aid trial period. Globally, there are no standardised frameworks or regulations on the recommended hearing aid trial period. The main purpose of this study was to explore audiologists' hearing aid trialing practices. A cross sectional study employed a quantitative, descriptive design to formulate the study. Ninety-five audiologists' were recruited by means of a purposive sampling strategy. Data were collected through the use of an online survey via Google forms. A pilot study was conducted prior to the commencement of the main study in order to ensure reliability of the main study. The results indicated that two weeks was the most recommended duration of a trial period from audiologists'. Majority of audiologists' (72.63%) offer hearing aid trials to their patients. Most audiologists' who offer hearing aid trials choose to trial their patients with two different hearing aids. Findings revealed a need for trialing periods to become standard practice by audiologists' when fitting hearing aids. Not enough audiologists' are providing this service.

Identifiers

PMID37922231
PMCPMC10624272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.